investors.aastrom.com
Investor Relations | Vericel CorporationLearn more about the stem cell therapeutics company, Vericel Corporation, including their mission, management and scientific advisory board.
http://investors.aastrom.com/
Learn more about the stem cell therapeutics company, Vericel Corporation, including their mission, management and scientific advisory board.
http://investors.aastrom.com/
TODAY'S RATING
>1,000,000
Date Range
HIGHEST TRAFFIC ON
Friday
LOAD TIME
PAGES IN
THIS WEBSITE
16
SSL
EXTERNAL LINKS
4
SITE IP
206.200.251.19
LOAD TIME
0 sec
SCORE
6.2
Investor Relations | Vericel Corporation | investors.aastrom.com Reviews
https://investors.aastrom.com
Learn more about the stem cell therapeutics company, Vericel Corporation, including their mission, management and scientific advisory board.
Stock Information - Vericel Corporation
http://investors.aastrom.com/stockquote.cfm
Our Missions & Values. Research & Development. Active Trials in Clinical Development. Financials & Filings. Annuals & Proxies. News & Events. Events & Presentations. Stock Quote & Chart. 3:59 PM ET on Aug 26, 2016. Sign up for email alerts. Financials & Filings. Annuals & Proxies. News & Events. Events & Presentations. Stock Quote & Chart. Our Missions & Values. Research & Development. Active Trials in Clinical Development. Financials & Filings. Annuals & Proxies. News & Events. Stock Quote & Chart.
Investor Relations - Vericel Corporation
http://investors.aastrom.com/index.cfm
Our Missions & Values. Research & Development. Active Trials in Clinical Development. Financials & Filings. Annuals & Proxies. News & Events. Events & Presentations. Stock Quote & Chart. Financials & Filings. Annuals & Proxies. News & Events. Events & Presentations. Stock Quote & Chart. Day High: 2.45. Day Low: 2.25. 3:59 PM ET on Aug 26, 2016. Delayed at least 20 minutes. Aug 8, 2016. Vericel Reports Second-Quarter 2016 Financial Results. Aug 1, 2016. View all press releases ». Aug 8, 2016 at 4:30 PM ET.
Vericel Announces Plan to Submit HDE Supplement to the FDA to Revise the Labeled Indications for Use and Add Pediatric Labeling for Epicel (NASDAQ:VCEL)
http://investors.aastrom.com/releasedetail.cfm?ReleaseID=921931
Jul 14, 2015. Vericel Announces Plan to Submit HDE Supplement to the FDA to Revise the Labeled Indications for Use and Add Pediatric Labeling for Epicel. Cultured epidermal autografts) to specifically include pediatric patients and to add pediatric labeling for Epicel. Epicel is a permanent skin replacement for the treatment of patients with deep dermal or full thickness burns comprising greater than or equal to 30% of total body surface area. Epicel has been used in the United States and internation...
Board of Directors - Vericel Corporation
http://investors.aastrom.com/directors.cfm
Our Missions & Values. Research & Development. Active Trials in Clinical Development. Financials & Filings. Annuals & Proxies. News & Events. Events & Presentations. Stock Quote & Chart. Robert L. Zerbe, M.D. - Chairman. CEO of QUATRx Pharmaceuticals Company. Vericel Corporation Board of Directors: Audit Committee, Compensation Committee, Governance Committee. Alan L. Rubino. CEO and President of Emisphere Technologies, Inc. Formerly Global Chief Operating Officer of SOTIO, LLC. Kevin F. McLaughlin.
Press Releases - Vericel Corporation
http://investors.aastrom.com/releases.cfm
Our Missions & Values. Research & Development. Active Trials in Clinical Development. Financials & Filings. Annuals & Proxies. News & Events. Events & Presentations. Stock Quote & Chart. Aug 8, 2016. Vericel Reports Second-Quarter 2016 Financial Results. Aug 1, 2016. Vericel to Host Second-Quarter 2016 Earnings Webcast and Conference Call on August 8, 2016. Jul 6, 2016. Vericel to Present at Cantor Fitzgerald's 2nd Annual Healthcare Conference. May 10, 2016. Apr 27, 2016. Apr 8, 2016. Apr 4, 2016. Active...
TOTAL PAGES IN THIS WEBSITE
16
Investors the World
Let's shared to be shared. Crude Oil Soars After OPEC and Non-OPEC Countries Agree to Production Cuts (USO, XOM). 12 December, 2016. Crude oil prices rose to their highest level in nearly a year and a half after both the Organization for Petroleum Exporting Countries (OPEC) and […]. 3 Notorious American White Collar Criminals. 4 September, 2016. 5 Advantages of Investing in Your 20s. 30 July, 2016. Types of Income the IRS Can’t Touch. 30 July, 2016. 29 July, 2016. 29 July, 2016. 29 July, 2016. Warren Edw...
Q4 Web Site Development
Q4 Web Maintenance Message. This site is currently under development and not yet available for public viewing. For more information on why this site is not available, please contact Q4.
4imprint - Investor Relations | Investor Information Home - 4imprint Group plc
Delayed by at least 15 minutes. Welcome to the 4imprint Group plc corporate website. Here you will find key financial data and company information. 4imprint Group is a UK listed leading international direct marketer of promotional products supplying promotional products under the brand name 4imprint. The Group's strategy is to deliver profitable organic growth, gaining market share in the large and highly fragmented markets in which it operates. Annual Report and Account 2014.
Investor Relations, 8x8, Inc.
Skip to main content. Annual Reports and Proxies. Annual Reports and Proxies. The world's first Communications Cloud Provider. 8x8 global cloud communications combine unified communications. Team collaboration interoperability, contact center. In a single open platform that integrates across clouds, applications and devices, eliminating information silos to expose vital, real-time intelligence. End of Day Stock Quote. Enter the code shown above. San Jose, Ca. 95131. Powered By Q4 Inc. Opens in new window).
A10 Networks – Investor Relations
Security and DMZ Optimization. Cloud IaaS Data Centers. Service Providers - Mobile. Thunder Series Product Lines. Thunder Application Delivery Controller (ADC). Thunder Carrier-Grade Networking (CGN). Thunder Threat Protection Systems (TPS). Thunder Hybrid Virtual Appliances. Global Server Load Balancing (GSLB). Firewall Load Balancing (FWLB). Carrier Grade NAT (CGNAT). Amazon Web Services (AWS). Annual Meeting of Stockholders. Management and Board of Directors. As of August 14, 2015 -. August 12, 2015.
Investor Relations | Vericel Corporation
Our Mission and Values. Living With DCM Video. About Critical Limb Ischemia. Living With CLI Video. Vericel in the News. Day High: 3.39. Day Low: 3.18. 4:00 PM ET on. Aug 7, 2015. Delayed 20 min., by eSignal. Jul 29, 2015. Vericel to Host Second-Quarter 2015 Earnings Webcast and Conference Call on August 12, 2015. Jul 14, 2015. Vericel Announces Plan to Submit HDE Supplement to the FDA to Revise the Labeled Indications for Use and Add Pediatric Labeling for Epicel. View all press releases ».
investors.abeonatherapeutics.com
Investor Relations Home | Investors | Abeona Therapeutics
Send Us A Message. Send Us A Message. Abeona Therapeutics is focused on developing and delivering gene therapy and plasma-based products for severe and life-threatening rare diseases. Developing therapies for rare disease requires new approaches and strong collaboration between researchers, industry, regulators and patient groups. Abeona was forged from the company’s close collaborations with key stakeholders all dedicated to transforming new biotechnology insights into breakthrough treatments fo...Sign ...
Accuray Incorporated - Investor Relations - Investor Relations Home
Sign Up for Email Alerts:. Accuray Incorporated is a radiation oncology company that develops, manufactures and sells precise, innovative treatment solutions that set the standard of care with the aim of helping patients live longer, better lives. The Company's leading-edge technologies deliver the full range of radiation therapy and radiosurgery treatments. 160; 0.09. Data as of 08/07/15 4:00 pm ET. Minimum 20 minute delay. Q4 2015 Accuray Incorporated Earnings Conference Call. Click here for webcast.
Q4 Web Site Development
Q4 Web Maintenance Message. This site is currently under development and not yet available for public viewing. For more information on why this site is not available, please contact Q4.
Investor Centre - Acrux
Welcome to the Acrux Limited investor centre. This section is designed to give current and potential investors access to our important public information. Welcome to the Acrux Limited investor centre. This section is designed to give current and potential investors access to our important public information. 2017 Half Year Result and Investor Call. An investor call was held on. 21 February 2017 to discuss the 2017 financial result and provide and update on Acrux strategy. An investor call was held on.
ActivumSG
By clicking Submit, I agree to the website Terms of Use. 2017 Powered by Backstop.
SOCIAL ENGAGEMENT